查找临床试验
已按「结直肠癌」检索，对应国际通用词 colorectal cancer
共找到 494 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 23:03，每 5 分钟自动同步正在招募II 期中国有中心NCT07044921
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
China
年龄 18 Years – 不限
Chinese PLA General Hospital
正在招募II 期中国有中心NCT07284992
SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC
China
年龄 18 Years – 80 Years
Shandong Provincial Hospital
正在招募I 期中国有中心NCT06821048
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
China
年龄 18 Years – 不限
Weijia Fang, MD
正在招募III 期中国有中心NCT06008119
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
China
年龄 18 Years – 70 Years
Shanghai Kechow Pharma, Inc.
正在招募不适用中国有中心NCT07026110
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
China
年龄 18 Years – 80 Years
RenJi Hospital
正在招募II 期中国有中心NCT07391618
Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU
China
年龄 18 Years – 75 Years
Chinese PLA General Hospital
正在招募不适用中国有中心NCT07557225
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
China
年龄 18 Years – 不限
Peking University First Hospital
正在招募不适用中国有中心NCT07352280
Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer
China
年龄 18 Years – 不限
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
正在招募不适用中国有中心NCT07676383
Precision Navigation to Improve Community Cancer Screening Participation
China
年龄 45 Years – 74 Years
Hunan Cancer Hospital
正在招募不适用中国有中心NCT05015296
The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal Cancer
China
年龄 18 Years – 85 Years
Beijing Friendship Hospital
正在招募II 期中国有中心NCT06590259
A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM
China
年龄 18 Years – 75 Years
Shanghai 6th People's Hospital
正在招募II 期中国有中心NCT07108127
Efficacy and Safety of Trastuzumab Biosimilars and Pertuzumab Biosimilars Combined With Chemotherapy for Neoadjuvant Treatment of Patients With Locally Advanced HER2-positive Rectal Cancer
China
年龄 18 Years – 不限
Peking Union Medical College Hospital